Our current study shows reduced activation and proliferation of NKG2C+ NK cells expressing NKR‐P1A receptor compared with those lacking NKR‐P1A in CMV seropositive individuals, which could contribute to the accumulation of NKR‐P1A‒ NK cells during CMV infection. The gene discussed is KLRC2; the disease is cytomegalovirus infection.